Week 1 Haemostasis and vascular pathology Flashcards

1
Q

Define haemostasis

A

Haemostasis is:

  • a precisely orchestrated series of regulatory processes which
  • culminates in the formation of a blood clot that
  • prevents further blood loss from the injured vessel
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List three things haemostasis allows

A
  • Blood to be in a fluid state in normal vessels
  • Formation of localised haemostatic clot at site of vascular injury
  • Prevents haemorrhage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List three key components of haemostasis

A

1) vascular wall
2) platelets
3) coagulation cascade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the basic blood vessel histology

A

1) Tunica intima- single layer squamous endothelium overlying basement membrane. BM overlies connective tissue and elastic layer
2) Tunica media- circularly arranged smooth muscle cells
3) Tunica adventitia- connective tissue, contains both vascular and neural supply.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Explain the role of endothelium both during normal physiology and during haemostasis.

A

Normally endothelium cells are:

  • antiplatelet
  • anticoagulant
  • fibrinolytic

Key: endothelium acts as a barrier between thrombogenic subendothelium and coagulation factors in the blood.

Endothelium also expresses factors which prevent thrombosis in undamaged vessels.

Limits clot formation to the site of injury.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the role of platelets in haemostasis

Describe the three stages by which platelets carry out their role.

A

Platelets:

  • Form the primary haemostatic plug
  • Provide a surface for the recruitment and concentration of coagulation factors. (activation exposes negatively charged phospholipid which binds coagulation factors and amplifies their activity).

Three stages of platelet activity:

1) Adhesion to the ECM at sites of vascular injury
2) Activation by the secretion of granules
3) Aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List sequence of events initiated at the site of vascular injury to maintain normal haemostasis

A

Step 1: Vasoconstriction

Step 2: Primary haemostasis (formation of the primary platelet plug after interaction with the vessel wall)

Step 3: Secondary haemostasis (formation of insoluble, cross linked fibrin by activated coagulation factors- Thrombin- which stabilises the primary platelet plug )

Step 4: Clot stabilisation and resorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe how vasoconstriction occurs

State what this achieves

A
  • Neurogenic reflex
  • Release of vasconstrictor endothelin by damaged endothelium
  • Minimises blood loss
  • Minimises interactions between platelets, clotting factors and the vessel wall
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the events in primary haemostasis

A
  • Damage to the vessel wall leads to exposure of the subendothelium containing collagen and other prothombotic elements such as vWF.
  • Platelets adhere to the exposed subendothelial matrix collagen and vWF and become activated
  • Activated platelets transform from their normal discoid shape to elongated cells with spikey cytoplasmic projections (increase in SA to recruit other platelets)
  • Activated platelets release their secretory granules (Degranulation). Secretory granules contain platelet agonists (e.g. thromboxane A2/ Serotonin and ADP) and coagulation factors and vWF.
  • Activated platelets also flip negatively charged phospholipid to the externam membrane providing a binding site for coagulation factors, amplifies their activity and promotes fibrin formation.
  • Cascade of adhesion, activation and aggregation to form the primary haemostatic plug.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Define seconday haemostasis

A
  • Secondary haemostasis is the formation of insoluble, cross- linked fibrin by activated coagulation factors- specifically thrombin. Leads to stabilisation of the primary platelet plug.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Outline the events of secondary haemostasis

(Do not go into detail about the whole coagulation cascade, focus on key end events)

A

Secondary haemostasis:

  • Exposure of Tissue factor (glycoprotein) on subendothlelial cells (SMC’s and fibroblasts) due to vessel wall damage
  • Binding of Factor VII to tissue factor which activates it and initiates the coagulation cascade.
  • Thrombin is generated which cleaves Fibrinogen into Fibrin
  • Formation of insoluble, cross linked fibrin meshwork that stabilises primary haemostatic plug.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the coagulation cascade

By what process does this allow a small amount of initating factor to produce a clot?

A
  • The coagulation cascade involves a series of proteolytic cleavages that convert inactive coagulation factors (proenzymes) to active coagulation factors (enzymes).
  • By a process of amplification this allows a small amount of initating factor to produce a clot.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What does the coagulation cascade require? (List 5)

A
  1. Active coagulation factors (produced by proteolytic cleavage of inactive coagulation of factors).
    * Factors XII, XI, X, IX, VII, and prothrombin
  2. Cofactors:
    * Acclerate the reaction, Factors V and VIII (5-8 ACCELERATE)
  3. Negatively charged phospholipid
    * Provided by the negatively charged phosphatidylserine on ACTIVATED platelets
  4. Ca2+
  5. Vitamin K:
  • Required for post translational modification and production of certain factors: (1972)
  • factors X, IX, VII, II (prothrombin).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the goal of the coagulation cascade?

What pathways are there that can leads to this?

A
  • To produce Thrombin which will convert Fibrinogen into Fibrin and stabilise the clot.
  • There is the extrinsic pathway (initiated by tissue factor) and the intrinsic pathway (when factor XII contacts negatively charged phospholipid on platelet membrane)
  • Extrinsic pathway and intrinsic pathway both converge on the common pathway (Activated factor Xa and cofactor V/ Ca2+ complex).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the extrinsic pathway:

  • initation
  • propagation
  • final products

What clinical test measures it? What conditions does this allow us to monitor?

A

Extrinsic pathway:

Initiation by Tissue factor (called extrinsic as the circualtion not usually exposed to TF).

Tissue factor activates factor VII (7) converting it to factor VIIa (7a).

Tissue factor, activated factor 7a and Ca2+ ions combine to form a complex that activates factor X and factor IX.

Conversion of factor X to factor Xa which initiates the common pathway. Results int the production of Thrombin and therefore fibrin.

Measure by prothrombin time which can be used to measure the effect of anticoagulant treatment (warfarin) and liver disease (liver produces prothrombin).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

State the main actions of thrombin related to the coagulation cascade

A

Thrombin’s main action is the conversion of Fibrinogen to fibrin.

It also amplifies to coagulation cascade by activating more Factor XI, factor VIII and factor V.

(Activation of factor XI in intrinsic pathway, factor VIII which is required to convert factor X- Xa alongside factor IX, and factor V which combines with Xa and Ca2+ to convert prothrombin to thrombin).

It also stabilises the haemostatic plug by activating factor 13 (XIII). Factor XIIIa converts soluble fibrin to cross linked fibrin therefore stabilising plug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

State three additional actions of thrombin that are not directly related to the coagulation cascade

A
  1. Thrombin has proinflammatory effects
  2. Thrombin contributes to normal tissue repair and angiogenesis
  3. Throbin has anticoagulant effects when interacting with intact healthy endothelium, limits clots to site of injury.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What factors limit the coagulation cascade?

A
  1. Dilution by the flow of blood washing coagulation factors away
  2. Limited by the amount of negatively charged SA provided by activated platelets
  3. Anticoagulants expressed by intact adjacent endothelium
  4. Antithrombin III which inhibits Thrombin, Factors 9/10/11/12 (is augmented by heparin liked modules expressed on intact endothelium).
  5. Fibronolytic cascade
19
Q

Name two drugs that can inhibit coagulation

A

1) Heparin
2) Warfarin

20
Q

What is heparin? How is it administered?

What is its mechanism of action?

What two forms does it come in?

What are its uses?

A

Heparin is a negatively charged glycosaminoglycan administered by IV injection.

It binds to and activates antithrombin III (which inhibits thrombin, factor 9/10/11/12).

Comes in two forms:

1) Unfractionated Heparin which inhibits both Thrombin and Factor Xa
2) Low molecular weight Heparin which inhibits only factor Xa.

Uses: Inhibits clotting at low doses and prevents progression of established clots (higher doses).

Used in prevention/prophylaxis and in treatment of venous thromboembolism.

21
Q

What is warfarin?

What is its mechanism of action?

What are its uses?

A
  • Warfarin is a vitamin K antagonist.
  • It binds to and inhibits the enzyme VKORC1 needed to reduce vitamin K.
  • Vitamin K is required for the postranslational modification of factor 10, 9, 7 , 2 (Thrombin).
  • Therefore Warfarin inhibits the synthesis of factor 10, 9, 7 and Thrombin.
  • Uses: Prophylaxis and treatment of venous thromboembolism and ischaemic stroke in atrial fibrillation.
22
Q

Name another class of drug that can be used in anticoagulation therapy that is not warfarin or heparin.

Name an example

Explain its mechanism of action.

A

NOAC= New oral anticoagulants

Example: Dabigatran

Mechanism of action: competitve reversible inhibitor of Thrombin

23
Q

Haemostasis steps:

1) reflex vasoconstriction
2) Primary haemostasis
3) Secondary haemostasis
4) ??? Describe what this last step is and what system it involves.

A
  • Step 4 of haemostasis: Clot stabilisation and fibrinolysis
  • Fibrinolysis involves the activation of plasmin from plasminogen.
  • Plasmin breaks down the fibrin clot.
  • Conversion of plasminogen to plasmin is initiated by either: 1) Factor XII dependent pathway 2) Plasminogen activators released by intact adjacent endothelium. (E.g. t-PA= Tissue plasminogen activator).
24
Q

Define haemorrhage

A

An extravasation of blood into the extravascular space.

25
Q

Define ischaemia

A

Inadequate flow of blood to a part of the body due to a constriction or blockage of the blood vessel supplying that region.

26
Q

Define infarction

A

Tissue death due to inadequate blood supply.

27
Q

Define thrombus

A

A thrombus is a solid mass of blood products in a vessel lumen.

28
Q

Define embolism

A

An obstruction to blood flow caused by a detached intravascular solid/liquid/gas that is carried by the blood to a site distant from its point of origin.

29
Q

Explains mechanisms of haemorrhage and factors affecting the clinical significance.

A

Mechanisms of haemorrhage:

Haemorrhage= extravasation of blood into the extravascular space

Extravascular spaces are: 1) Tissues 2) Body cavities 3) outside of the body

Factors affecting the clinical significance:

VRMS

V- Volume of blood lost- significant ability to compensate

R- Rate of blood loss will affect our ability to compensate, can compensate higher blood loss if over a long period of time

M- Medical fitness of patient pre blood loss

S- Site of blood loss e.g. small volume haemorrhages have significant consequences when intracranial

30
Q

What is the difference between haemostasis and thrombosis?

A

Haemostasis is a physiological process that allows:

  1. Blood to be in a fluid state
  2. The formation of a localised haemostatic plug at the site of vascular injury
  3. When this doesnt occur it results in haemorrhage.

Thrombosis is a pathological process that:

  1. Results in the formation of a solid mass of blood products in an intravascular lumen that occludes blood flow
  2. Can leads to ischaemia and infarction.
31
Q

What is Virchow’s triad?

List the factors in Virchow’s triad.

A

Virchows triad explains the three factors that can lead to thrombus formation.

1) Endothelial injury
2) Abnormal blood flow
3) Hypercoaguability of blood

Both endothelial dysfunction and abnormal blood flow can cause the other and vice versa. Both endothelial dysfunction and abnormal blood flow can cause hypercoagulabilty of blood.

32
Q

Use Virchow’s triad to explain the pathogenesis of thrombus:

1) Endothelial injury

What does endothelial injury refer to?

What type of thrombi is is the main cause of?

What are these thrombi rich in and therefore what are they treated with?

What are the causes of endothelial injury?

A
  • Endothelial injury refers to both physical damage to endothelium and endothelial dysfunction.
  • Endothelial dysfunction occurs when the expression profile switches from anticoagulant to procoagulant
  • Endothelial injury is the commonest cause of arterial and intracardiac thrombi where high rates of blood flow impede clot formation.
  • They are rich in platelets and are therefore treated with antiplatelet drugs e.g. aspirin
  • Causes: Smoking (O2 free radicals, toxins), hypertension, turbulent blood flow, bacterial endotoxins
33
Q

Use virchow’s triad to explain the pathogenesis of thrombus:

2) Abnormal blood flow

List two types of abnormal blood flow and explain how they link to thrombus formation

A

1) Stasis: slow flowing blood e.g. in veins (DVT). In static blood flow:

  • Loss of laminar flow - platelets and leukocytes come into contact with endothelium
  • Loss of washout of coagulation factors
  • Loss of inflow of coagulation inhibitors

2) Turbulent blood flow:

  • Occurs in arteries and the heart (e.g. Atrial Fibrillation)
  • Loss of laminar flow: Creation of eddies that lead to focal stasis of blood
  • Can be caused by endothelial injury/ dysfunction

Both Stasis and Turbulent blood flow promote procoagulant gene expression in endothelium- abnormal blood flow promotes endothelial dysfunction.

34
Q

Use Virchow’s triad to explain the pathogenesis of thrombus formation:

3) Hypercoaguability

What can cause hypercoagulant states?

A

1) Acquired disorders:

  • Dehydration
  • Post operatively
  • disseminated carcinoma
  • Heparin induced thrombocytopenia

2) Inherited disorders:
* In factor 5/ Prothrombin genes

35
Q

What are the clinical consequences of thrombi?

A

1) Cause obstruction of blood flow:

Arterial- cause ischaemia and infarction

Venous- Congestion and oedema

2) Embolism:

Causing obstuction and infarction of distal tissues

36
Q

List the fates of thrombi:

A
  1. Propagation: Expansion and growth of the thrombus by futher addition of platelets and fibrin deposition. Can lead to occlusion or embolism.
  2. Embolisation: Detachment of part of thrombus from origin to lodge at distant site. Can cause occlusion and infarction.
  3. Resolution/ Dissolution: Fibrinolysis and and autolytic degeneration of cellular components of thrombus. Leads to restoration of blood flow.
  4. Organisation: Ingrowth of granulation tissue and fibrous repair. (Endothelial cells grow over the thrombus forming new channels). Or recanilisation - new channel forms in the organising thrombus.
37
Q

What are emboli classified by?

A
  1. Site: Pulmonary or systemic
  2. Material embolising: Examples:
  • Thromboembolism - disolodged thrombus (most common)
  • Air- decompression sickness
  • Fat- massive soft tissue trauma, broken bones, orthopaedic surgery
  • Amniotic fluid embolism
38
Q

List the types of emboli

A

1) Arterial thromboembolism
2) Venous thromboembolism (DVT)
3) Pulmonary (Thrombo) embolism (PE)

Last two often termed together as venous thromboembolism as both DVT and PE are closely linked

39
Q

What is an arterial thrombosis?

What usually causes them?

What is their effect?

What are they a source of?

Given an example of a thrombus site and its clinical effect

A
  • Is a thrombus that forms within an arterial vessel
  • Usually caused by rupture of atheromatous plaque caused by turbulent blood flow and endothelial dysfunction
  • Effect: Occludes blood supply causing ischaemic necrosis/ infarction.
  • Source of emboli
  • Example: Thrombosis in coronary artery leading to MI
40
Q

What are the common sites of origin of an arterial thromboembolism?

What are common loding sites for arterial thromboemboli?

A

Origin sites:

  • Heart- Left ventricle- secondary to MI or valve dysfunction
  • Heart- Left atrium- atrial fibrillation
  • Arterial vessels: Aortic aneurysm or atheromatous plaque

Lodging sites:

  • CNS- Stroke
  • Lower extremities- limb ischaemia
  • Intestines- bowel ischaemia
  • Kidneys/ spleen- can be asymptomatic
41
Q

What is a venous thrombosis?

What is it associated with?

What conditions in a patient can cause it?

How might it present in a patient?

A
  • Venous thrombosis refers to Deep vein thrombosis (DVT) in the deep veins of the legs/ pelvis (Iliac veins).
  • Associated with hypercoaguability and stasis of blood.
  • Conditions in patient that can cause it:
  • Bed rest or immobilisation - stasis of blood flow
  • Pregnancy- blood stasis with uterus enlargement and hypercoaguability
  • Post surgical- immobilisation, vascular injury and release of procoagulant factors.
  • It may not present at all- 50% asymptomatic
  • If it does present could have pain, erythema, swelling, tenderness, increased temperature
42
Q

What is a pulmonary embolism?

What is its route?

What is the clinical significance?

What clinical signs will a patient show?

A
  • Is an embolism within the pulmonary circulation disolodged from a DVT.
  • Route: DVT- Veins- R side heart- Pulmonary arteries
  • Clinical significance depends on both size and site of embolism within the lungs.
  • May be asymptomatic
  • Multiple small emboli over a prolonged period can present with pulmonary hypertension
  • May occlude small/ medium vessels leading to cardiac and respiratory symptoms
  • May lead to tissue infarction
  • Sudden death if large embolus in the main pulmonary arteries
  • Signs/ Symptoms: SOB, pleuritic chest pain (on inspiration), haemoptysis, cough, tachycardia and tachypnea, hypoxia
43
Q

What can cause infarction?

List common cause first

(6 more if poss)

A
  • Infarction most commonly caused by arterial thrombosis and embolism. Examples include MI, Cerebral infarction, Bowel infarction, gangrene.
  • Infarction can also be caused by venous thrombosis but not as common. Normally in venous thrombosis collateral vessels quickly open up to allow drainage. If there is only 1 venous outflow however (ovaries and testes) it can lead to infarction.
  • Vasospasm
  • Expansion of atheroma due to intraplaque haemorrhage
  • extrinsic compression of vessel eg tumour
  • oedma in confined space- compartment syndrome
  • vessel twisting eg testicular torsion